ロード中...
AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy
There is growing epidemiological evidence indicating an association between diabetes mellitus and the increased incidence of colorectal cancer (CRC). The preferred initial and most widely used pharmacological agent for the treatment of type 2 diabetes is metformin, which in parallel reduces the risk...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781747/ https://ncbi.nlm.nih.gov/pubmed/31612008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10800 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|